Non-myeloablative allogeneic stem cell transplantation (NST) vs. autologous transplantation (ASCT) in patients with mantle cell lymphoma (MCL)

被引：0
|
作者：
Khouri, I. F. [1 ]
Tam, C. S. [1 ]
Ledesma, C. [1 ]
Champlin, R. E. [1 ]
机构：
[1] Univ Texas Houston, MD Anderson Canc Ctr, Stem Cell Transplantat & Cellular Therapy, Houston, TX 77030 USA
来源：
ANNALS OF ONCOLOGY | 2008年 / 19卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：86 / 86
页数：1
相关论文
共 50 条
  • [21] Autologous non-myeloablative hematopoietic stem cell transplantation (NST) for severe systemic lupus erythematosus.
    Burt, RK
    Oyama, Y
    Statkute, L
    Krosnjar, N
    Verda, L
    Kowalska, B
    Traynor, AE
    BLOOD, 2004, 104 (11) : 46A - 46A
  • [22] Non-Myeloablative Stem Cell Transplantation
    Robert Marcus
    Bone Marrow Transplantation, 2001, 27 (6) : 667 - 667
  • [23] Comparison of Autologous Vs. Allogeneic Stem Cell Transplantation for Non-Hodgkin Lymphoma
    Reddy, Nishitha M.
    Oluwole, Olalekan O.
    Greer, John P.
    Morgan, David S.
    Goodman, Stacey
    Engelhardt, Brian
    Chinratanalab, Wichai
    Kassim, Adetola A.
    Jagasia, Madan
    Savani, Bipin N.
    BLOOD, 2012, 120 (21)
  • [24] Comparison of renal injury in myeloablative autologous, myeloablative allogeneic and non-myeloablative allogeneic haematopoietic cell transplantation
    Schrier, RW
    Parikh, CR
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2005, 20 (04) : 678 - 683
  • [25] Non myeloablative allogeneic stem cell transplantation (NST) in patients with high risk lymphoma:: A single centre experience
    Console, G.
    Moscato, T.
    Messina, G.
    Martino, M.
    Irrera, G.
    Pucci, G.
    Massara, E.
    Fedele, R.
    Cuzzola, M.
    Pontan, A.
    Callea, I
    Dattola, A.
    Condemi, A.
    Rigolino, C.
    Meliadò, A.
    Marcuccio, D.
    Gatto, F.
    Stelitano, C.
    Callea, V
    Mamone, D.
    Kropp, Mg
    Molica, S.
    Focarile, E.
    Pinto, A.
    Iacopino, P.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 202 - 202
  • [26] NON MYELOABLATIVE ALLOGENEIC STEM CELL TRANSPLANTATION (NST) IN PATIENTS WITH HIGH RISK LYMPHOMA: A SINGLE CENTRE EXPERIENCE
    Console, G.
    Messina, G.
    Martino, M.
    Moscato, T.
    Fedele, R.
    Massara, E.
    Irrera, G.
    BONE MARROW TRANSPLANTATION, 2014, 49 : S446 - S446
  • [27] Quality of life in patients undergoing non-myeloablative (NST) versus myeloablative (MT) allogeneic peripheral blood stem cell transplantation (PBSCT).
    Bevans, M
    Marden, S
    Leidy, N
    Soeken, K
    Rivera, P
    Cusack, G
    Mayberry, H
    Bishop, M
    Barrett, J
    BLOOD, 2003, 102 (11) : 722A - 722A
  • [28] AUTOLOGOUS NON-MYELOABLATIVE HEMATOPOIETIC STEM CELL TRANSPLANTATION IN PATIENTS WITH SYSTEMIC SCLEROSIS
    Milanetti, Francesca
    Bucha, Jurate
    Kwasny, Mary
    Boyce, Kristin
    Quigley, Kate
    Yaung, Kim
    Burt, Richard K.
    BONE MARROW TRANSPLANTATION, 2010, 45 : S23 - S23
  • [29] Autologous non-myeloablative hematopoietic stem cell transplantation in patients with systemic sclerosis
    Y Oyama
    W G Barr
    L Statkute
    T Corbridge
    E A Gonda
    B Jovanovic
    A Testori
    R K Burt
    Bone Marrow Transplantation, 2007, 40 : 549 - 555
  • [30] Autologous non-myeloablative hematopoietic stem cell transplantation in patients with systemic sclerosis
    Oyama, Y.
    Barr, W. G.
    Statkute, L.
    Corbridge, T.
    Gonda, E. A.
    Jovanovic, B.
    Testori, A.
    Burt, R. K.
    BONE MARROW TRANSPLANTATION, 2007, 40 (06) : 549 - 555
12345